Definium Therapeutics (DFTX)
Nasdaq • DFTX • CA24477V1058
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 8.9% of free float sold short, 5.2 days to cover, cost to borrow 0.43%. Sign up for live short interest data.
Market Cap
4.47b USD | # 2625 in US
Volume
2.16m shares | 82.64m USD
Shares Outstanding
134.37m
Free Float Shares
93.42% | 125.52m
